• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病诊断和预后的残留向量。

Residual vectors for Alzheimer disease diagnosis and prognostication.

出版信息

Brain Behav. 2011 Nov;1(2):142-52. doi: 10.1002/brb3.19.

DOI:10.1002/brb3.19
PMID:22399094
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3236543/
Abstract

Alzheimer disease (AD) is an increasingly prevalent neurodegenerative condition and a looming socioeconomic threat. A biomarker for the disease could make the process of diagnosis easier and more accurate, and accelerate drug discovery. The current work describes a method for scoring brain images that is inspired by fundamental principles from information retrieval (IR), a branch of computer science that includes the development of Internet search engines. For this research, a dataset of 254 baseline 18-F fluorodeoxyglucose positron emission tomography (FDG-PET) scans was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI). For a given contrast, a subset of scans (nine of every 10) was used to compute a residual vector that typified the difference, at each voxel, between the two groups being contrasted. Scans that were not used for computing the residual vector (the remaining one of 10 scans) were then compared to the residual vector using a cosine similarity metric. This process was repeated sequentially, each time generating cosine similarity scores on 10% of the FDG-PET scans for each contrast. Statistical analysis revealed that the scores were significant predictors of functional decline as measured by the Functional Activities Questionnaire (FAQ). When logistic regression models that incorporated these scores were evaluated with leave-one-out cross-validation, cognitively normal controls were discerned from AD with sensitivity and specificity of 94.4% and 84.8%, respectively. Patients who converted from mild cognitive impairment (MCI) to AD were discerned from MCI nonconverters with sensitivity and specificity of 89.7% and 62.9%, respectively, when FAQ scores were brought into the model. Residual vectors are easy to compute and provide a simple method for scoring the similarity between an FDG-PET scan and sets of examples from a given diagnostic group. The method is readily generalizable to any imaging modality. Further interdisciplinary work between IR and clinical neuroscience is warranted.

摘要

阿尔茨海默病(AD)是一种日益普遍的神经退行性疾病,也是一个迫在眉睫的社会经济威胁。疾病的生物标志物可以使诊断过程更容易、更准确,并加速药物发现。目前的工作描述了一种基于信息检索(IR)基本原理的脑图像评分方法,IR 是计算机科学的一个分支,包括互联网搜索引擎的开发。在这项研究中,从阿尔茨海默病神经影像学倡议(ADNI)获得了 254 例基线 18-F 氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)扫描的数据集。对于给定的对比,使用扫描的子集(每 10 个中的 9 个)来计算残差向量,该向量典型地表示对比的两组之间每个体素的差异。然后,使用余弦相似性度量将未用于计算残差向量的扫描(剩余的 10 个扫描中的一个)与残差向量进行比较。这个过程依次重复,每次为每个对比生成 10%的 FDG-PET 扫描的余弦相似得分。统计分析表明,这些分数是功能活动问卷(FAQ)测量的功能下降的显著预测因子。当使用留一交叉验证评估包含这些分数的逻辑回归模型时,认知正常对照者与 AD 之间的灵敏度和特异性分别为 94.4%和 84.8%。当将 FAQ 分数纳入模型时,从轻度认知障碍(MCI)转化为 AD 的患者与 MCI 非转化者之间的灵敏度和特异性分别为 89.7%和 62.9%。残差向量易于计算,并为 FDG-PET 扫描与给定诊断组的示例集之间的相似性提供了一种简单的评分方法。该方法易于推广到任何成像模式。IR 和临床神经科学之间需要进一步的跨学科工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/fa577614684a/brb30001-0142-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/f3533ed39ca7/brb30001-0142-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/3ebf13fdf1cb/brb30001-0142-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/17333ca10d17/brb30001-0142-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/9cdddc4831e3/brb30001-0142-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/fa577614684a/brb30001-0142-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/f3533ed39ca7/brb30001-0142-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/3ebf13fdf1cb/brb30001-0142-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/17333ca10d17/brb30001-0142-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/9cdddc4831e3/brb30001-0142-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd69/3236543/fa577614684a/brb30001-0142-f5.jpg

相似文献

1
Residual vectors for Alzheimer disease diagnosis and prognostication.阿尔茨海默病诊断和预后的残留向量。
Brain Behav. 2011 Nov;1(2):142-52. doi: 10.1002/brb3.19.
2
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.非痴呆患者的 FDG-PET 扫描在预测未来认知和功能下降速度方面的价值。
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1355-1363. doi: 10.1007/s00259-017-3634-3. Epub 2017 Mar 22.
3
Equal sensitivity of early and late scans after injection of FDG for the detection of Alzheimer pattern: an analysis of 3D PET data from J-ADNI, a multi-center study.注射 FDG 后早期和晚期扫描对阿尔茨海默病模式检测的敏感性相当:来自 J-ADNI 的 3D PET 数据分析,一项多中心研究。
Ann Nucl Med. 2013 Jun;27(5):452-9. doi: 10.1007/s12149-013-0704-x. Epub 2013 Mar 13.
4
Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.用于轻度认知障碍向阿尔茨海默病转化预后评估的脑氟代脱氧葡萄糖正电子发射断层显像统计单受试者分析的优化
J Alzheimers Dis. 2016;49(4):945-959. doi: 10.3233/JAD-150814.
5
Multimodal classification of Alzheimer's disease and mild cognitive impairment.阿尔茨海默病和轻度认知障碍的多模态分类。
Neuroimage. 2011 Apr 1;55(3):856-67. doi: 10.1016/j.neuroimage.2011.01.008. Epub 2011 Jan 12.
6
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.AD 和 MCI 认知、功能和 FDG-PET 测量下降之间的关联。
Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5.
7
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data.基于图谱的磁共振衰减校正对阿尔茨海默病 FDG-PET/MR 诊断的影响——结合多中心数据和 ADNI 数据的模拟研究。
PLoS One. 2020 Jun 3;15(6):e0233886. doi: 10.1371/journal.pone.0233886. eCollection 2020.
8
Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.评估校准的(18)F-FDG PET 评分作为阿尔茨海默病和轻度认知障碍进展的生物标志物。
J Nucl Med. 2011 Aug;52(8):1218-26. doi: 10.2967/jnumed.111.090902. Epub 2011 Jul 15.
9
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.使用 ADNI 的基线数据联合评估定量 18F-氟比他派和 18F-FDG 区域摄取。
J Alzheimers Dis. 2018;62(1):399-408. doi: 10.3233/JAD-170833.
10
Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.多模态神经影像学生物标志物预测进展性轻度认知障碍。
J Alzheimers Dis. 2016;51(4):1045-56. doi: 10.3233/JAD-151010.

引用本文的文献

1
2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.阿尔茨海默病神经影像学计划2014年更新:自启动以来发表论文综述
Alzheimers Dement. 2015 Jun;11(6):e1-120. doi: 10.1016/j.jalz.2014.11.001.
2
Latent information in fluency lists predicts functional decline in persons at risk for Alzheimer disease.流畅性列表中的潜在信息可预测阿尔茨海默病高危人群的功能衰退。
Cortex. 2014 Jun;55:202-18. doi: 10.1016/j.cortex.2013.12.013. Epub 2014 Jan 16.
3
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

本文引用的文献

1
Comparing predictors of conversion and decline in mild cognitive impairment.比较轻度认知障碍转归和衰退的预测因素。
Neurology. 2010 Jul 20;75(3):230-8. doi: 10.1212/WNL.0b013e3181e8e8b8. Epub 2010 Jun 30.
2
Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.利用 ADNI 数据库对阿尔茨海默病患者的结构 MRI 进行自动分类:十种方法的比较。
Neuroimage. 2011 May 15;56(2):766-81. doi: 10.1016/j.neuroimage.2010.06.013. Epub 2010 Jun 11.
3
Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.
阿尔茨海默病神经影像学倡议:成立以来发表论文的综述。
Alzheimers Dement. 2013 Sep;9(5):e111-94. doi: 10.1016/j.jalz.2013.05.1769. Epub 2013 Aug 7.
4
Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI.采用国立衰老研究所-阿尔茨海默病协会 AD 标准对 ADNI 进行分析。
Neurology. 2013 Jun 4;80(23):2130-7. doi: 10.1212/WNL.0b013e318295d6cf. Epub 2013 May 3.
5
Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.阿尔茨海默病中使用分期生物标志物和免疫疗法的分子成像前景
ScientificWorldJournal. 2013;2013:589308. doi: 10.1155/2013/589308. Epub 2013 Feb 5.
将磁共振成像、正电子发射断层扫描和脑脊液生物标志物相结合,用于阿尔茨海默病的诊断和预后。
AJNR Am J Neuroradiol. 2010 Feb;31(2):347-54. doi: 10.3174/ajnr.A1809. Epub 2010 Jan 14.
4
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.AD 和 MCI 认知、功能和 FDG-PET 测量下降之间的关联。
Neurobiol Aging. 2011 Jul;32(7):1207-18. doi: 10.1016/j.neurobiolaging.2009.07.002. Epub 2009 Aug 5.
5
Resting-state functional connectivity reflects structural connectivity in the default mode network.静息态功能连接反映默认模式网络中的结构连接。
Cereb Cortex. 2009 Jan;19(1):72-8. doi: 10.1093/cercor/bhn059. Epub 2008 Apr 9.
6
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)提高了鉴别额颞叶痴呆和阿尔茨海默病的准确性。
Brain. 2007 Oct;130(Pt 10):2616-35. doi: 10.1093/brain/awm177. Epub 2007 Aug 18.
7
(18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.经纵向确认的健康老年人的(18)F-FDG PET数据库可提高对轻度认知障碍和阿尔茨海默病的检测。
J Nucl Med. 2007 Jul;48(7):1129-34. doi: 10.2967/jnumed.107.040675. Epub 2007 Jun 15.
8
Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study.卡巴拉汀对从轻度认知障碍发展到阿尔茨海默病的诊断延迟的影响:InDDEx研究
Lancet Neurol. 2007 Jun;6(6):501-12. doi: 10.1016/S1474-4422(07)70109-6.
9
Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.通过基因评估和(18)F-FDG PET预测轻度认知障碍的个体临床结局。
J Nucl Med. 2005 Oct;46(10):1625-32.
10
Vitamin E and donepezil for the treatment of mild cognitive impairment.维生素E与多奈哌齐治疗轻度认知障碍
N Engl J Med. 2005 Jun 9;352(23):2379-88. doi: 10.1056/NEJMoa050151. Epub 2005 Apr 13.